Several neurological manifestations are part of the post-COVID condition. We aimed to: (1) evaluate the 6-month outcome in the cohort of patients with neurological manifestations during the COVID-19 acute phase and surviving the infection, and find outcome predictors; (2) define the prevalence and type of neurological symptoms persistent at six months after the infection. Data source was an international registry of patients with COVID-19 infection and neurological symptoms, signs or diagnoses established by the European Academy of Neurology. Functional status at six-month follow-up was measured with the modified Rankin scale (mRS), and defined as: "stable/improved" if the mRS at six months was equal as or lower than the baseline score; "worse" if it was higher than the baseline score. By October 30, 2022, 1,003 lab-confirmed COVID-19 patients were followed up for a median of 6.5 months. Compared to their pre-morbid status, 522 patients (52%) were stable/improved, whereas 465 (46%) were worse (functional status missing for 16). Age, hospitalization, several pre-COVID-19 comorbidities, and COVID-19 general complications were predictors of a worse status. Amongst neurological manifestations, stroke carried the highest risk for worse outcome (OR 5.96), followed by hyperactive delirium (2.8), and peripheral neuropathies (2.37). On the other hand, hyposmia/hypogeusia (0.38), headache (0.40), myalgia (0.45), and COVID-19 vaccination (0.52) were predictors of a favourable prognosis. Persisting neurological symptoms or signs were reported by 316/1003 patients (31.5%), the commonest being fatigue (n = 133), and impaired memory or concentration (n = 103). Our study identified significant long-term prognostic predictors in patients with COVID-19 and neurological manifestations.

Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry / Leone, M. A.; Helbok, R.; Bianchi, E.; Yasuda, C. L.; Konti, M.; Ramankulov, D.; Lolich, M.; Lovrencic-Huzjan, A.; Kovacs, T.; Armon, C.; Cotelli, M. S.; Cavallieri, F.; Grosu, O.; Kiteva-Trenchevska, G.; Rodriguez-Leyva, I.; Boldingh, M.; Brola, W.; Maia, L. F.; de Seabra, M. M. L.; Davidescu, E. I.; Popescu, B. O.; Kopishinskaia, S.; Bassetti, C. L. A.; Moro, E.. - In: JOURNAL OF NEUROLOGY. - ISSN 1432-1459. - 271:6(2024), pp. 3153-3168. [10.1007/s00415-024-12212-8]

Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry

Cavallieri F.;Moro E.
2024

Abstract

Several neurological manifestations are part of the post-COVID condition. We aimed to: (1) evaluate the 6-month outcome in the cohort of patients with neurological manifestations during the COVID-19 acute phase and surviving the infection, and find outcome predictors; (2) define the prevalence and type of neurological symptoms persistent at six months after the infection. Data source was an international registry of patients with COVID-19 infection and neurological symptoms, signs or diagnoses established by the European Academy of Neurology. Functional status at six-month follow-up was measured with the modified Rankin scale (mRS), and defined as: "stable/improved" if the mRS at six months was equal as or lower than the baseline score; "worse" if it was higher than the baseline score. By October 30, 2022, 1,003 lab-confirmed COVID-19 patients were followed up for a median of 6.5 months. Compared to their pre-morbid status, 522 patients (52%) were stable/improved, whereas 465 (46%) were worse (functional status missing for 16). Age, hospitalization, several pre-COVID-19 comorbidities, and COVID-19 general complications were predictors of a worse status. Amongst neurological manifestations, stroke carried the highest risk for worse outcome (OR 5.96), followed by hyperactive delirium (2.8), and peripheral neuropathies (2.37). On the other hand, hyposmia/hypogeusia (0.38), headache (0.40), myalgia (0.45), and COVID-19 vaccination (0.52) were predictors of a favourable prognosis. Persisting neurological symptoms or signs were reported by 316/1003 patients (31.5%), the commonest being fatigue (n = 133), and impaired memory or concentration (n = 103). Our study identified significant long-term prognostic predictors in patients with COVID-19 and neurological manifestations.
2024
271
6
3153
3168
Outcome predictors of post-COVID conditions in the European Academy of Neurology COVID-19 registry / Leone, M. A.; Helbok, R.; Bianchi, E.; Yasuda, C. L.; Konti, M.; Ramankulov, D.; Lolich, M.; Lovrencic-Huzjan, A.; Kovacs, T.; Armon, C.; Cotelli, M. S.; Cavallieri, F.; Grosu, O.; Kiteva-Trenchevska, G.; Rodriguez-Leyva, I.; Boldingh, M.; Brola, W.; Maia, L. F.; de Seabra, M. M. L.; Davidescu, E. I.; Popescu, B. O.; Kopishinskaia, S.; Bassetti, C. L. A.; Moro, E.. - In: JOURNAL OF NEUROLOGY. - ISSN 1432-1459. - 271:6(2024), pp. 3153-3168. [10.1007/s00415-024-12212-8]
Leone, M. A.; Helbok, R.; Bianchi, E.; Yasuda, C. L.; Konti, M.; Ramankulov, D.; Lolich, M.; Lovrencic-Huzjan, A.; Kovacs, T.; Armon, C.; Cotelli, M. ...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1355227
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact